High-dose, high-precision radiation therapy safe and effective for kidney cancer patients with only one kidney
Treatment of renal cell carcinoma with SABR is as safe and effective for patients with one kidney as it is for those who have two, according to an analysis of the largest-ever, international dataset of solitary kidney patients to receive this emerging treatment. SABR has been shown to be effective in treating cancers in the lung, liver and spine using substantially
higher doses of radiation delivered in a single, or just a few, treatment sessions. The abstract was presented at ASTRO 2018 by lead author Rohann J. M. Correa, MD, PhD, with London Health Sciences Center in London, Canada